Juvenile Paget's Disease

745 Users are discussing this topic

PatientPlus articles are written by UK doctors and are based on research evidence, UK and European Guidelines. They are designed for health professionals to use, so you may find the language more technical than the condition leaflets.

This page has been archived. It has not been updated since 28/09/2011. External links and references may no longer work.

Synonyms: chronic congenital idiopathic hyperphosphatasemia, familial idiopathic hyperphosphatasia, familial osteoectasia, hereditary hyperphosphatasia, hyperostosis corticalis deformans juvenilis

There is generalised increase in bone turnover leading to widespread bony deformities in childhood with bone pain.[1] Some patients may have milder forms.[2][3]

The juvenile form of Paget's disease is different from the adult form. It is autosomal recessive, with gene locus 8q24 and results from mutations or deletions in the TNFRSF11B gene.[3] These lead to a deficiency of osteoprotegerin, a member of the TNF-receptor superfamily.[4] Osteoprotegerin inhibits osteoclast differentiation and bone resorption.[5]

This is an extremely rare condition.

NEW - log your activity

  • Notes
    Add notes to any clinical page and create a reflective diary
  • Track
    Automatically track and log every page you have viewed
  • Print
    Print and export a summary to use in your appraisal
Click to find out more »

Presentation is in early infancy with:

  • Bone deformity with pain.
  • Failure to thrive.
  • Dwarfism.
  • Progressive enlargement of the head.
  • Bowed limbs.
  • Difficulty walking.
  • Pigeon breast deformity.
  • Muscular weakness.
  • Premature shedding of the teeth.[3]
  • Retinal degeneration (± angioid streaks).
  • Recurrent renal colic from calcium-containing stones.
  • Internal carotid aneurysms (one case report).[6]
  • Blood tests - reveal raised alkaline phosphatase (ALP).
  • Urine - raised hydroxyproline.
  • Plain X-rays - there is enlargement and thickening of bones, eg the skull vault.
  • Children need to be advised on a healthy diet with adequate calcium and vitamin D intake. This should be combined with physical activity regimens where possible.
  • The use of anti-resorptive drugs, such as the bisphosphonates, eg pamidronate or calcitonin, has led to clinical, biological and radiological improvement.[5][7][8]
  • Some work suggests the use of intensive bisphosphonate therapy, but this may lead to osteopetrosis.[5][9]
  • Recombinant versions of osteoprotegerin are under research.[10]

Severity of the disease increases as the child progresses towards adolescence. Some patients will survive beyond the age of 50 years.

Further reading & references

  1. Ralston SH, Langston AL, Reid IR; Pathogenesis and management of Paget's disease of bone. Lancet. 2008 Jul 12;372(9633):155-63.
  2. Golob DS, McAlister WH, Mills BG, et al; Juvenile Paget disease: life-long features of a mildly affected young woman. J Bone Miner Res. 1996 Jan;11(1):132-42.
  3. Juvenile Paget Disease; Online Mendelian Inheritance in Man (OMIM)
  4. Hofbauer LC, Schoppet M; Osteoprotegerin deficiency and juvenile Paget's disease. N Engl J Med. 2002 Nov 14;347(20):1622-3; author reply 1622-3.
  5. Ralston SH; Juvenile Paget's disease, familial expansile osteolysis and other genetic osteolytic disorders. Best Pract Res Clin Rheumatol. 2008 Mar;22(1):101-11.
  6. Allen CA, Hart BL, Taylor CL, et al; Bilateral cavernous internal carotid aneurysms in a child with juvenile paget disease and osteoprotegerin deficiency. AJNR Am J Neuroradiol. 2008 Jan;29(1):7-8. Epub 2007 Oct 18.
  7. Silve C; Hereditary hypophosphatasia and hyperphosphatasia. Curr Opin Rheumatol. 1994 May;6(3):336-9.
  8. Tuysuz B, Mercimek S, Ungur S, et al; Calcitonin treatment in osteoectasia with hyperphosphatasia (juvenile Paget's disease): radiographic changes after treatment. Pediatr Radiol. 1999 Nov;29(11):838-41.
  9. Cundy T, Wheadon L, King A; Treatment of idiopathic hyperphosphatasia with intensive bisphosphonate therapy. J Bone Miner Res. 2004 May;19(5):703-11. Epub 2004 Jan 19.
  10. Cundy T, Davidson J, Rutland MD, et al; Recombinant osteoprotegerin for juvenile Paget's disease. N Engl J Med. 2005 Sep 1;353(9):918-23.
  11. Skowronska-Jozwiak E, Lorenc RS; Metabolic bone disease in children : etiology and treatment options. Treat Endocrinol. 2006;5(5):297-318.

Disclaimer: This article is for information only and should not be used for the diagnosis or treatment of medical conditions. EMIS has used all reasonable care in compiling the information but make no warranty as to its accuracy. Consult a doctor or other health care professional for diagnosis and treatment of medical conditions. For details see our conditions.

Original Author:
Dr Gurvinder Rull
Current Version:
Peer Reviewer:
Dr John Cox
Document ID:
9316 (v2)
Last Checked:
Next Review:

Did you find this health information useful?

Yes No

Thank you for your feedback!

Subcribe to the Patient newsletter for healthcare and news updates.

We would love to hear your feedback!

Patient Access app - find out more Patient facebook page - Like our page